Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

84.18
Delayed Data
As of Mar 24
 -0.24 / -0.28%
Today’s Change
64.18
Today|||52-Week Range
86.14
+14.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$92.9B

Company Description

Eli Lilly & Co. discovers, develops, manufactures and sells pharmaceutical products. It operates through the Human Pharmaceutical Products and Animal Health segments. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The Other Pharmaceuticals products include anti-infectives, primarily Vancocin and Ceclor, and other miscellaneous pharmaceutical products and services. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Contact Information

Eli Lilly & Co.
Lilly Corporate Center
Indianapolis Indiana 46285
P:(317) 276-2000
Investor Relations:

Employees

Shareholders

Mutual fund holders37.90%
Other institutional27.40%
Individual stakeholders11.88%

Top Executives

David A. RicksPresident, Chief Executive Officer & Director
Derica W. RiceChief Financial Officer & EVP-Global Services
Aarti ShahChief Information Officer & Senior Vice President
Melissa Stapleton BarnesSenior VP, Chief Ethics & Compliance Officer
Jeffrey N. SimmonsSenior Vice President